Longitudinal impact of the Women's Health Initiative study on hormone therapy use in Australia.

CONCLUSIONS: MHT use remained low after 2002 despite evidence favoring its use in women younger than 60 years or within 10 years postmenopause. Continued low use could relate to the WHI 2002 media coverage, therapy objectives, key stakeholder uncertainty, health policies, and medicine availability.
PMID: 31010331 [PubMed - as supplied by publisher]

Source: Climacteric - April 22, 2019 Category: Geriatrics Authors: Natari RB, McGuire TM, Baker PJ, Clavarino AM, Dingle KD, Hollingworth SA Tags: Climacteric Source Type: research